NuVasive Announces Educational Initiatives In Support Of Spine’s Fastest Growing Spinal Deformity Portfolio

  • 02/06/2017 - Company news

NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced the Company’s increased investment and support of adult and pediatric deformity research, education, and awareness initiatives throughout 2017.

Read more

ATTUNE® Knee System Four-Year Revision Rate is Lower Than Total Knee Class, According to New & Independent Joint Registry Data

  • 01/06/2017 - Products

DePuy Synthes*, part of the Johnson & Johnson Family of Companies, today announced new ATTUNE® Knee implant survivorship data based on an independent analysis of 10,605 ATTUNE Knee implantations, showing that the cumulative revision rate for the ATTUNE Knee is 1.3% at four years (98.7% implant survivorship at four years), comparing favorably to the 1.9% cumulative revision rate (98.1% implant survivorship at four years) for the overall class of total knee replacement.1

Read more

VEXIM: ANVISA Approves SpineJack® Implants in Brazil

  • 31/05/2017 - Company news

VEXIM (Paris:ALVXM) (FR0011072602 - ALVXM), a medical device company specializing in the minimally invasive treatment of vertebral fractures, today announces it has received the regulatory approval from ANVISA1, Brazil’s National Health Surveillance Agency, in order to commercialize the SpineJack® in Brazil.

Read more

Paragon 28® launches the industry's most robust screw and instrumentation system for addressing Jones fractures - PRECISION™ Jones Fracture Screw System

  • 31/05/2017 - Tech news

Since its inception, Paragon 28 has obsessed over every aspect of foot and ankle surgery. Committed to creating tailored solutions to improve surgical outcomes, Paragon 28 has launched innovative products and instrumentation that help to streamline procedures, allow surgeons flexibility in technique and approach, and facilitate reproducible results benefitting both the surgeon and patient.

Read more

K2M’s New Surgical Solutions to Enhance MESA® 2 Deformity Spinal System with Next-Generation Cricket™ Technology

  • 30/05/2017 - Products

K2M Group Holdings, Inc. (NASDAQ:KTWO) (the “Company” or “K2M”), a global leader of complex spine and minimally invasive solutions focused on achieving three-dimensional Total Body Balance™, today announced the launch of the MESA 2 Cricket™, an enhancement to the Company’s innovative MESA® 2 Deformity Spinal System.

Read more

NovaBone Announces Irrigation Resistant Products with Carriers that have Synergistic Effect in Bone Formation

  • 29/05/2017 - Company news

NovaBone Products, a leading biologics medical device company, announces the addition of NovaBone IRM and NovaBone IRM MacroPOR to its portfolio of biologically active bone graft substitutes.

Read more

OrthoMemphis Performs First Meniscus Replacement in Tennessee with NUsurface® Implant

  • 24/05/2017 - Company news

MEMPHIS, Tenn.--(BUSINESS WIRE)--OrthoMemphis and Active Implants, a Memphis-based company that develops orthopedic implant solutions, today announced that the first meniscus replacement procedure in Tennessee was successfully performed.

Read more

BONESUPPORT™ Announces First Patient Enrolled in FORTIFY Trial with CERAMENT®|G

  • 24/05/2017 - Tech news

Lund, Sweden, 22 May 2017– BONESUPPORT AB, an emerging leader in innovative injectable bioceramic bone substitute products to treat bone voids caused by trauma, infection, disease or related surgery, today announced that the first patient has been enrolled by Dr Ravi Karia at the University of Texas Health Science Center at San Antonio into the company’s pivotal Investigational Device Exemption (IDE) trial: A Prospective, Randomized, Multicenter Controlled Trial of CERAMENT G as Part of Surgical Repair of Open Diaphyseal Tibial Fractures (the FORTIFY trial: ClinicalTrials.gov Identifier: NCT02820363).

Read more
1 2 3 4 5 6 7 8 9